Back to mobile site

Jefferies Reiterates Buy Rating on Pfizer (PFE)

June 4, 2025 5:37 AM EDT Send to a Friend
Jefferies analyst Akash Tewari reiterated a Buy rating and $33.00 price target on Pfizer (NYSE: PFE).The analyst comments "Bottom line ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login